Zeitschriftenartikel zum Thema „T cells Receptors“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "T cells Receptors" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Y, Elshimali. „Chimeric Antigen Receptor T-Cell Therapy (Car T-Cells) in Solid Tumors, Resistance and Success“. Bioequivalence & Bioavailability International Journal 6, Nr. 1 (2022): 1–6. http://dx.doi.org/10.23880/beba-16000163.
Meiliana, Anna, Nurrani Mustika Dewi und Andi Wijaya. „CAR T Cells: Precision Cancer Immunotherapy“. Indonesian Biomedical Journal 10, Nr. 3 (28.12.2018): 203–16. http://dx.doi.org/10.18585/inabj.v10i3.635.
Steverding, Dietmar. „Cycle Numbers of Cell Surface Recycling Receptors“. Receptors 2, Nr. 2 (06.06.2023): 160–65. http://dx.doi.org/10.3390/receptors2020010.
Coico, R. F., B. Xue, D. Wallace, B. Pernis, G. W. Siskind und G. J. Thorbecke. „T cells with receptors for IgD“. Nature 316, Nr. 6030 (August 1985): 744–46. http://dx.doi.org/10.1038/316744a0.
Klein, Thomas W., Cathy Newton, Kellie Larsen, Joe Chou, Izabella Perkins, Lily Lu, Liang Nong und Herman Friedman. „Cannabinoid receptors and T helper cells“. Journal of Neuroimmunology 147, Nr. 1-2 (Februar 2004): 91–94. http://dx.doi.org/10.1016/j.jneuroim.2003.10.019.
Rossig, Claudia, Catherine M. Bollard, Jed G. Nuchtern, Cliona M. Rooney und Malcolm K. Brenner. „Epstein-Barr virus–specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy“. Blood 99, Nr. 6 (15.03.2002): 2009–16. http://dx.doi.org/10.1182/blood.v99.6.2009.
Sato, Noriko, Richard N. Bamford, Bonita R. Bryant, Yutaka Tagaya und Thomas A. Waldmann. „Accessory cells precondition naive T cells and regulatory T cells for cytokine-mediated proliferation“. Journal of Immunology 210, Nr. 1_Supplement (01.05.2023): 164.02. http://dx.doi.org/10.4049/jimmunol.210.supp.164.02.
Suzuki, T., und M. D. Cooper. „Comparison of the expression of IL 2 receptors by human T and B cells: induction by the polyclonal mitogens, phorbol myristate acetate, and anti-mu antibody.“ Journal of Immunology 134, Nr. 5 (01.05.1985): 3111–19. http://dx.doi.org/10.4049/jimmunol.134.5.3111.
Scheurich, P., B. Thoma, U. Ucer und K. Pfizenmaier. „Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses.“ Journal of Immunology 138, Nr. 6 (15.03.1987): 1786–90. http://dx.doi.org/10.4049/jimmunol.138.6.1786.
Aune, T. M., K. M. McGrath, T. Sarr, M. P. Bombara und K. A. Kelley. „Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine.“ Journal of Immunology 151, Nr. 3 (01.08.1993): 1175–83. http://dx.doi.org/10.4049/jimmunol.151.3.1175.
Kamiya, Takahiro, Desmond Wong, Yi Tian Png und Dario Campana. „A novel method to generate T-cell receptor–deficient chimeric antigen receptor T cells“. Blood Advances 2, Nr. 5 (05.03.2018): 517–28. http://dx.doi.org/10.1182/bloodadvances.2017012823.
Posnett, D. N., A. Gottlieb, J. B. Bussel, S. M. Friedman, N. Chiorazzi, Y. Li, P. Szabo, N. R. Farid und M. A. Robinson. „T cell antigen receptors in autoimmunity.“ Journal of Immunology 141, Nr. 6 (15.09.1988): 1963–69. http://dx.doi.org/10.4049/jimmunol.141.6.1963.
Wu, Ling, Qianru Wei, Joanna Brzostek und Nicholas R. J. Gascoigne. „Signaling from T cell receptors (TCRs) and chimeric antigen receptors (CARs) on T cells“. Cellular & Molecular Immunology 17, Nr. 6 (25.05.2020): 600–612. http://dx.doi.org/10.1038/s41423-020-0470-3.
Kim, Chang H., Jeeho Lee und Seung G. Kang. „Developmental and antigen-driven switches in the trafficking receptors of FoxP3+ regulatory T cells (99.2)“. Journal of Immunology 178, Nr. 1_Supplement (01.04.2007): S194. http://dx.doi.org/10.4049/jimmunol.178.supp.99.2.
Umemura, Masayuki, Masatoshi Yamasaki, Toshiki Tamura und Goro Matsuzaki. „Dispensable role of chemokine receptors in migration of mycobacterial antigen-specific CD4+ T cells into mycobacteria-infected lung“. Journal of Immunology 204, Nr. 1_Supplement (01.05.2020): 156.34. http://dx.doi.org/10.4049/jimmunol.204.supp.156.34.
Baldanzi, Gianluca. „Immune Checkpoint Receptors Signaling in T Cells“. International Journal of Molecular Sciences 23, Nr. 7 (24.03.2022): 3529. http://dx.doi.org/10.3390/ijms23073529.
Kochenderfer, James N. „Chimeric Antigen Receptors/Genetically Modified T-Cells“. Blood 128, Nr. 22 (02.12.2016): SCI—37—SCI—37. http://dx.doi.org/10.1182/blood.v128.22.sci-37.sci-37.
Modlin, Robert L., Michael B. Brenner, Michael S. Krangel, Allan D. Duby und Barry R. Bloom. „T-cell receptors of human suppressor cells“. Nature 329, Nr. 6139 (Oktober 1987): 541–45. http://dx.doi.org/10.1038/329541a0.
Tordai, A., J. W. Fenton, T. Andersen und E. W. Gelfand. „Functional thrombin receptors on human T lymphoblastoid cells.“ Journal of Immunology 150, Nr. 11 (01.06.1993): 4876–86. http://dx.doi.org/10.4049/jimmunol.150.11.4876.
Zhang, Peng-Fei, Chuang Wang, Le Zhang und Qiu Li. „Reversing chemokine/chemokine receptor mismatch to enhance the antitumor efficacy of CAR-T cells“. Immunotherapy 14, Nr. 6 (April 2022): 459–73. http://dx.doi.org/10.2217/imt-2021-0228.
Cameron, W., K. Doyle und R. E. Rocklin. „Histamine type I (H1) receptor radioligand binding studies on normal T cell subsets, B cells, and monocytes.“ Journal of Immunology 136, Nr. 6 (15.03.1986): 2116–20. http://dx.doi.org/10.4049/jimmunol.136.6.2116.
Rabin, Ronald L., Matthew K. Park, Fang Liao, Ruth Swofford, David Stephany und Joshua M. Farber. „Chemokine Receptor Responses on T Cells Are Achieved Through Regulation of Both Receptor Expression and Signaling“. Journal of Immunology 162, Nr. 7 (01.04.1999): 3840–50. http://dx.doi.org/10.4049/jimmunol.162.7.3840.
Meeks, Christian Matthew, und Christopher G. Horton. „Modulation of CD4+ T cell polarization using non-canonical co-receptors“. Journal of Immunology 198, Nr. 1_Supplement (01.05.2017): 150.15. http://dx.doi.org/10.4049/jimmunol.198.supp.150.15.
Frydrychowicz, Magdalena, Maciej Boruczkowski, Agata Kolecka-Bednarczyk, Renata Jenek, Joanna Rosołowska, Agnieszka Pluto-Prądzyńska und Grzegorz Dworacki. „Characteristics of Regulatory T cells“. Journal of Medical Science 85, Nr. 4 (29.12.2016): 323–26. http://dx.doi.org/10.20883/jms.2016.175.
Frydrychowicz, Magdalena, Maciej Boruczkowski, Agata Kolecka-Bednarczyk, Renata Jenek, Joanna Rosołowska, Agnieszka Pluto-Prądzyńska und Grzegorz Dworacki. „Characteristics of Regulatory T cells“. Journal of Medical Science 85, Nr. 4 (29.12.2016): 323. http://dx.doi.org/10.20883/175.
Portilla, Didier, und Mark D. Okusa. „T cells and T-cell receptors in acute renal failure“. Kidney International 69, Nr. 2 (Januar 2006): 208–10. http://dx.doi.org/10.1038/sj.ki.5000128.
Kempkes, B., E. Palmer, S. Martin, A. von Bonin, K. Eichmann, B. Ortmann und H. U. Weltzien. „Predominant T cell receptor gene elements in TNP-specific cytotoxic T cells.“ Journal of Immunology 147, Nr. 8 (15.10.1991): 2467–73. http://dx.doi.org/10.4049/jimmunol.147.8.2467.
Cardarelli, P. M., und M. D. Pierschbacher. „Identification of fibronectin receptors on T lymphocytes.“ Journal of Cell Biology 105, Nr. 1 (01.07.1987): 499–506. http://dx.doi.org/10.1083/jcb.105.1.499.
Dailey, M. O., J. Schreurs und H. Schulman. „Hormone receptors on cloned T lymphocytes. Increased responsiveness to histamine, prostaglandins, and beta-adrenergic agents as a late stage event in T cell activation.“ Journal of Immunology 140, Nr. 9 (01.05.1988): 2931–36. http://dx.doi.org/10.4049/jimmunol.140.9.2931.
Rosenberg, Kenneth M., und Nevil J. Singh. „Subset-specific neurotransmitter receptor expression tunes T cell activation“. Journal of Immunology 200, Nr. 1_Supplement (01.05.2018): 47.22. http://dx.doi.org/10.4049/jimmunol.200.supp.47.22.
Robson MacDonald, H., Rosemary K. Lees und Werner Held. „Developmentally Regulated Extinction of Ly-49 Receptor Expression Permits Maturation and Selection of NK1.1+ T Cells“. Journal of Experimental Medicine 187, Nr. 12 (15.06.1998): 2109–14. http://dx.doi.org/10.1084/jem.187.12.2109.
Osborne, Douglas, und Daniel Billadeau. „Role of SNX17 in receptor recycling and antigen recognition by T cells. (IRC2P.445)“. Journal of Immunology 192, Nr. 1_Supplement (01.05.2014): 58.2. http://dx.doi.org/10.4049/jimmunol.192.supp.58.2.
Fortune, F., J. Freysdottir und J. Walker. „T cells expressing γδ receptors and Fcα receptors in Behcet's disease“. Immunology Letters 56 (Mai 1997): 308. http://dx.doi.org/10.1016/s0165-2478(97)86241-4.
Bebes, Attila, Ferenc Kovács-Sólyom, Judit Prihoda, Róbert Kui, Lajos Kemény und Rolland Gyulai. „Interleukin-1 Receptors Are Differentially Expressed in Normal and Psoriatic T Cells“. Mediators of Inflammation 2014 (2014): 1–9. http://dx.doi.org/10.1155/2014/472625.
ARMSTRONG, John M., Jiang Fan CHEN, Michael A. SCHWARZSCHILD, Sergey APASOV, Patrick T. SMITH, Charles CALDWELL, Pearl CHEN et al. „Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes: studies of cells from A2A-receptor-gene-deficient mice“. Biochemical Journal 354, Nr. 1 (08.02.2001): 123–30. http://dx.doi.org/10.1042/bj3540123.
Speiser, Daniel E., Mikaël J. Pittet, Danila Valmori, Rod Dunbar, Donata Rimoldi, Danielle Liénard, H. Robson MacDonald, Jean-Charles Cerottini, Vincenzo Cerundolo und Pedro Romero. „In Vivo Expression of Natural Killer Cell Inhibitory Receptors by Human Melanoma–Specific Cytolytic T Lymphocytes“. Journal of Experimental Medicine 190, Nr. 6 (20.09.1999): 775–82. http://dx.doi.org/10.1084/jem.190.6.775.
Schwab, R., M. K. Crow, C. Russo und M. E. Weksler. „Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.“ Journal of Immunology 135, Nr. 3 (01.09.1985): 1714–18. http://dx.doi.org/10.4049/jimmunol.135.3.1714.
Hannum, C., P. Marrack, R. Kubo und J. Kappler. „Thymocytes with the predicted properties of pre-T cells.“ Journal of Experimental Medicine 166, Nr. 4 (01.10.1987): 874–89. http://dx.doi.org/10.1084/jem.166.4.874.
Mazerolles, Fabienne, und Frédéric Rieux-Laucat. „PD-L1 is expressed on human activated naive effector CD4+ T cells. Regulation by dendritic cells and regulatory CD4+ T cells“. PLOS ONE 16, Nr. 11 (18.11.2021): e0260206. http://dx.doi.org/10.1371/journal.pone.0260206.
Simon, Bianca, Dennis C. Harrer, Beatrice Schuler-Thurner, Gerold Schuler und Ugur Uslu. „Arming T Cells with a gp100-Specific TCR and a CSPG4-Specific CAR Using Combined DNA- and RNA-Based Receptor Transfer“. Cancers 11, Nr. 5 (20.05.2019): 696. http://dx.doi.org/10.3390/cancers11050696.
Helsen, Christopher, Vivian Lau, Joanne Hammill, Kenneth Mwawasi, Danielle Hayes, Arya Afsahi, Ksenia Bezverbnaya, Craig Aarts, Galina Denisova und Jonathan Bramson. „T Cells Engineered with T Cell Antigen Coupler (TAC) Receptors for Haematological Malignancies“. Blood 132, Supplement 1 (29.11.2018): 3267. http://dx.doi.org/10.1182/blood-2018-99-119045.
Smith, Tracey J., und John H. Weis. „Mucosal T cells and mast cells share common adhesion receptors“. Immunology Today 17, Nr. 2 (Februar 1996): 60–63. http://dx.doi.org/10.1016/0167-5699(96)80580-9.
Biffen, M., und D. R. Alexander. „Mobilization of intracellular Ca2+ by adenine nucleotides in human T-leukaemia cells: evidence for ADP-specific and P2y-purinergic receptors“. Biochemical Journal 304, Nr. 3 (15.12.1994): 769–74. http://dx.doi.org/10.1042/bj3040769.
Weiss, A., P. F. Dazin, R. Shields, S. M. Fu und L. L. Lanier. „Functional competency of T cell antigen receptors in human thymus.“ Journal of Immunology 139, Nr. 10 (15.11.1987): 3245–50. http://dx.doi.org/10.4049/jimmunol.139.10.3245.
Peeters, Marlies J. W., Anne Rahbech und Per thor Straten. „TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting“. Cancer Immunology, Immunotherapy 69, Nr. 2 (29.10.2019): 237–44. http://dx.doi.org/10.1007/s00262-019-02421-w.
Shanker, Anil, Maria Teresa Prudente de Aquino, Thomas W. Hodo und Roman Uzhachenko. „Glutamate receptor signaling is critical for T cell function and antitumor activity“. Journal of Immunology 204, Nr. 1_Supplement (01.05.2020): 241.42. http://dx.doi.org/10.4049/jimmunol.204.supp.241.42.
Chen, Yuehong, Jianhong Sun, Huan Liu, Geng Yin und Qibing Xie. „Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases“. Journal of Immunology Research 2019 (31.12.2019): 1–9. http://dx.doi.org/10.1155/2019/5727516.
Batorov, E. V., V. A. Aristova, G. Yu Ushakova, S. A. Sizikova, V. V. Denisova, E. Ya Shevela, A. A. Ostanin und E. R. Chernykh. „Common Ɣ-chain cytokine receptors as functional phenotype markers of PD-1and TIM-3-positive T cells in multiple myeloma“. Siberian journal of oncology 22, Nr. 1 (22.02.2023): 43–54. http://dx.doi.org/10.21294/1814-4861-2023-22-1-43-54.
Zhou, Maggie, und Henrique Borges da Silva. „Tumor-induced, TCR-independent upregulation of A2AR expression in effector CD8+ T cells“. Journal of Immunology 208, Nr. 1_Supplement (01.05.2022): 121.05. http://dx.doi.org/10.4049/jimmunol.208.supp.121.05.
Jung, T. M., W. M. Gallatin, I. L. Weissman und M. O. Dailey. „Down-regulation of homing receptors after T cell activation.“ Journal of Immunology 141, Nr. 12 (15.12.1988): 4110–17. http://dx.doi.org/10.4049/jimmunol.141.12.4110.